Search Results 771-780 of 15285 for alt

  1. Liver transplant - Doctors & Departments - Mayo Clinic

    2025; doi:10.52604/alt.25.0004. Taner T, et al. Summary of a consensus conference on the management of highly sensitized multiorgan transplant candidates ...

  2. A Study to Investigate the Effectiveness and Safety of Cannabidiol (GWP42003-P; CBD) as an Added Treatment for the Seizures Associated with Lennox-Gastaut Syndrome in Children and Adults - Mayo Clinic

    Alanine aminotransferase [ALT] >5 x upper limit of normal [ULN]; Or total bilirubin [TBL] >2 x ULN; Or the ALT or Aspartate aminotransferase (AST) >3 x ULN ...

  3. Liver transplant - Doctors & Departments - Mayo Clinic

    2025; doi:10.52604/alt.25.0004. Taner T, et al. Summary of a consensus conference on the management of highly sensitized multiorgan transplant candidates ...

  4. Liver transplant - Doctors & Departments - Mayo Clinic

    2025; doi:10.52604/alt.25.0004. Taner T, et al. Summary of a consensus conference on the management of highly sensitized multiorgan transplant candidates ...

  5. A Study to Evaluate Tazemetostat Combined with Lenalidomide Plus Rituximab in Subjects With Relapsed/Refractory Follicular Lymphoma - Mayo Clinic

    Alkaline phosphatase (ALP) (in the absence of bone disease), alanine aminotransferase (ALT), and aspartate aminotransferase (AST) ≤3 × ULN (≤5 × ULN if ...

  6. Liver transplant - Doctors & Departments - Mayo Clinic

    2025; doi:10.52604/alt.25.0004. Taner T, et al. Summary of a consensus conference on the management of highly sensitized multiorgan transplant candidates ...

  7. Liver transplant - Doctors & Departments - Mayo Clinic

    2025; doi:10.52604/alt.25.0004. Taner T, et al. Summary of a consensus conference on the management of highly sensitized multiorgan transplant candidates ...

  8. Iobenguane I-131 Or Crizotinib And Standard Therapy In Treating Younger Patients With Newly-Diagnosed High-Risk Neuroblastoma Or Ganglioneuroblastoma - Mayo Clinic

    ... [ALT]) < 10 x ULN; for the purposes of this study, ULN for SGPT (ALT) is 45 - Shortening fraction of >= 27% by echocardiogram, or ejection fraction of ...

  9. Rifaximin for the Treatment of Gastrointestinal Toxicities Related to Pertuzumab-Based Therapy in Patients With Stage I-III HER2 Positive Breast Cancer - Mayo Clinic

    AST (SGOT)/ALT (SGPT) ≤ 2.5 x ULN;; Serum or plasma creatinine ≤ 1.5 x ULN;; Calculated creatinine clearance ≥ 45 ml/min using the Cockcroft-Gault formula ...

  10. Study of Durvalumab + Tremelimumab With Chemotherapy or Durvalumab With Chemotherapy or Chemotherapy Alone for Patients With Lung Cancer (POSEIDON). - Mayo Clinic

    ALT and AST ≤2.5 × ULN; for patients with hepatic metastases, ALT and AST;; ≤ × ULN;; Calculated creatinine clearance (CL) ≥40 mL/min as determined by ...